Eloxx Pharmaceuticals News and Activities
Presence
Headquarters: United States (USA)
Eloxx Pharmaceuticals is a company listed under the stock ticker ELOX (US).
Executives
View the org chart displaying its 10 main executives
Most searched biographies at Eloxx Pharmaceuticals
- Sumit Aggarwal, President, Chief Executive Officer and Director
- Tomer Kariv, Chairman of the Board
- Lindsay Androski, Director
Create your alert
to follow the executive moves at Eloxx Pharmaceuticals.
Pharmaceuticals
Eloxx Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (posted on June 4 2026).
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Eloxx Pharmaceuticals
- Eloxx Pharmaceuticals Announces Changes to Board of Directors | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Announces Therapeutic Development Award from Cystic Fibrosis Foundation | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports Fourth Quarter 2021 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Announces New Development Program for ELX-02 for the Treatment of Alport Syndrome | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020 | Eloxx Pharmaceuticals, Inc.
- Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins Eloxx Pharmaceuticals as a Senior Consultant | Eloxx Pharmaceuticals, Inc.
- Eloxx Announces Two Preclinical Abstracts Accepted for Presentation at the 2020 North American Cystic Fibrosis Virtual Conference in October | Eloxx Pharmaceuticals, Inc.
- Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis Has Resumed After Being Paused in Response to the COVID-19 Pandemic | Eloxx Pharmaceuticals, Inc.
- Eloxx Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results and Provides Business Update | Eloxx Pharmaceuticals, Inc.
- View more press releases Close
Social media about Eloxx Pharmaceuticals
- Eloxx Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Eloxx Pharmaceuticals on LinkedIn, X (Twitter) & YouTube
